VEGFA and neoplasm: Another aspect of interest in this regard is the production of VEGF-A splice variants in cancers such as VEGF-A165b.26, 27 This splice variant is capable of binding to VEGF receptor-2 (R2) but with inhibitory effects, thus decreasing the angiogenic tumor response.28